Design of a potent and selective inhibitor of the intermediate-conductance Ca(2+)-activated K(+) channel, IKCa1: A potential immunosuppressant
The antimycotic clotrimazole, a potent inhibitor of the intermediate-conductance calcium-activated K(+) channel, IKCa1, is in clinical trials for the treatment of sickle cell disease and diarrhea and is effective in ameliorating the symptoms of rheumatoid arthritis. However, inhibition of cytochrome...
Tallennettuna:
| Julkaisussa: | Proc Natl Acad Sci U S A |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
National Academy of Sciences
2000
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC16685/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10884437/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.97.14.8151 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
